These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9108773)

  • 21. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain.
    Olave T; Cornudella R; Homs C; Azaceta G; Tirado I; Gutierrez M
    Haematologica; 1998 Apr; 83(4):378-80. PubMed ID: 9592991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypercoagulability in a patient with meningioma and Factor VLeiden mutation].
    Gils C; Frøslev-Friis C
    Ugeskr Laeger; 2014 Oct; 176(43):. PubMed ID: 25353676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human protein C and thromboembolic disease.
    Gardiner JE; Griffin JH
    Prog Hematol; 1983; 13():265-78. PubMed ID: 6422505
    [No Abstract]   [Full Text] [Related]  

  • 25. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The results of diagnostic studies for thrombophilia in a large group of patients with a personal or family history of thrombosis.
    Dumenco LL; Blair AJ; Sweeney JD
    Am J Clin Pathol; 1998 Nov; 110(5):673-82. PubMed ID: 9802354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Screening in activated protein C resistance].
    Bergmann F
    Internist (Berl); 1997 Sep; 38(9):864. PubMed ID: 9410836
    [No Abstract]   [Full Text] [Related]  

  • 29. Resistance to activated protein C and risk of premature myocardial infarction.
    Samani NJ; Lodwick D; Martin D; Kimber P
    Lancet; 1994 Dec; 344(8938):1709-10. PubMed ID: 7996989
    [No Abstract]   [Full Text] [Related]  

  • 30. Factor V Leiden and thrombophilia.
    Simioni P; Scudeller A; Girolami A
    N Engl J Med; 1995 May; 332(20):1382. PubMed ID: 7715653
    [No Abstract]   [Full Text] [Related]  

  • 31. The natural anticoagulants.
    Salem HH
    Clin Haematol; 1986 May; 15(2):371-91. PubMed ID: 3015466
    [No Abstract]   [Full Text] [Related]  

  • 32. ARMS test for diagnosis of factor VLeiden mutation, a common cause of inherited thrombotic tendency.
    Yandava CN; Zappulla DC; Korf BR; Neufeld EJ
    J Clin Lab Anal; 1996; 10(6):414-7. PubMed ID: 8951612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Activated protein C resistance and mutation of coagulation factor V].
    Samama MM
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):669-70. PubMed ID: 8760650
    [No Abstract]   [Full Text] [Related]  

  • 35. Activated protein C resistance and inherited thrombosis.
    Rodgers GM
    Am J Clin Pathol; 1995 Mar; 103(3):261-2. PubMed ID: 7872247
    [No Abstract]   [Full Text] [Related]  

  • 36. Structure and function of protein C.
    Stenflo J
    Semin Thromb Hemost; 1984 Apr; 10(2):109-21. PubMed ID: 6429858
    [No Abstract]   [Full Text] [Related]  

  • 37. [Activated protein C resistance as a cause of thrombophilia].
    Ruiz-Argüelles GJ
    Rev Invest Clin; 1996; 48(3):223-9. PubMed ID: 8966383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated protein C resistance and the factor V Leiden mutation in children with thrombosis.
    Sifontes MT; Nuss R; Hunger SP; Waters J; Jacobson LJ; Manco-Johnson M
    Am J Hematol; 1998 Jan; 57(1):29-32. PubMed ID: 9423813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of activated protein C resistance and antibodies to phospholipids in the development of thrombosis.
    Bokarewa MI; Blombäck M
    Semin Hematol; 1997 Jul; 34(3):235-43. PubMed ID: 9241708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
    Dahlbäck B; Zöller B; Hillarp A
    Haemostasis; 1996 Oct; 26 Suppl 4():301-14. PubMed ID: 8979136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.